跳至主要内容
临床试验/NL-OMON47875
NL-OMON47875招募中不适用

The DIPAK Observational Cohort Study: a multi-center, longitudinal, observational study to investigate renal disease progression and association of disease biomarkers with renal disease progression and ADPKD-related outcomes. - The DIPAK Observational Cohort Study

niversitair Medisch Centrum Groningen0 个研究点目标入组 750 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
750

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Diagnosis of ADPKD, based upon the modified Ravine criteria or documented by
  • nephrologist or internist.
  • 2. Age 18 years and older.
  • 3. Providing informed consent.

排除标准

  • Patients, who are unlikely to adequately comply with the trial*s procedures
  • (due for instance to medical condition likely to require an extended
  • interruption or discontinuation)
  • Patients taking medications or having concomitant illnesses that are likely
  • to influence the natural course of ADPKD (e.g. nephrotoxic medications such as
  • chronic NSAID, cyclosporine, lithium and immunosuppressant use, and e.g.
  • diabetes mellitus and patients with proteinuria > 1 g/24hr).
  • Patients, who receive renal function replacement therapy
  • Pregnancy at moment of inclusion
  • Patients with a life expectancy less than 1 year at moment of inclusion

研究者

相似试验

The DIPAK Observational Cohort Study: a... | 临床试验